Instillagel(®) (CliniMed, High Wycombe, UK) is commonly used in urethral catheterisation and to facilitate the passage of instruments into the bladder in urological practice. Its active ingredients include 0.25% chlorhexidine, 2% lidocaine, 0.06% methyl hydroxybenzoate and 0.025% propyl hydroxybenzoate. We discuss the case of an 84-year-old man who received intraurethral Instillagel(®) prior to laser ablation of a recurrent transitional cell carcinoma of the bladder, resulting in anaphylaxis. Subsequent investigation confirmed allergy to chlorhexidine. Although there are previous reports in the literature, this is the first report of intraurethral chlorhexidine resulting in anaphylaxis in a patient who had had repeated, uneventful previous exposures. As such, this case illustrates the phenomenon of chlorhexidine sensitisation and that previous uneventful exposures do not exclude the diagnosis of anaphylaxis in the context of sudden, unexpected deterioration.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188324PMC
http://dx.doi.org/10.1308/003588413X13629960047597DOI Listing

Publication Analysis

Top Keywords

intraurethral chlorhexidine
8
chlorhexidine sensitisation
8
sensitisation previous
8
repeated uneventful
8
chlorhexidine
5
anaphylactic reaction
4
reaction intraurethral
4
previous
4
previous repeated
4
uneventful administration
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!